Literature DB >> 31548786

Medical Management of Neurogenic Bladder for Children and Adults: A Review.

Elizabeth Lucas1.   

Abstract

Neurogenic bladder is a chronic condition affecting patients of all ages with significant medical and quality of life implications. Goals of treatment consist of protection of the upper urinary tract and promotion of reliable urinary continence. Successful management involves medications and most often bladder drainage via clean intermittent catheterization. This article reviews current literature on medical management to achieve goals of treatment.

Entities:  

Keywords:  catheterization; myelomeningocele; neurogenic bladder; spinal cord injury

Mesh:

Substances:

Year:  2019        PMID: 31548786      PMCID: PMC6743750          DOI: 10.1310/sci2503-195

Source DB:  PubMed          Journal:  Top Spinal Cord Inj Rehabil        ISSN: 1082-0744


  107 in total

Review 1.  Prevention and management of urinary tract infections in paralyzed persons.

Authors:  B G Vickrey; P Shekelle; S Morton; K Clark; M Pathak; C Kamberg
Journal:  Evid Rep Technol Assess (Summ)       Date:  1999-01

2.  Side-effects of oral or intravesical oxybutynin chloride in children with spina bifida.

Authors:  P Ferrara; C M D'Aleo; E Tarquini; S Salvatore; E Salvaggio
Journal:  BJU Int       Date:  2001-05       Impact factor: 5.588

Review 3.  Conservative treatment of the neuropathic bladder in spinal cord injured patients.

Authors:  J J Wyndaele; H Madersbacher; A Kovindha
Journal:  Spinal Cord       Date:  2001-06       Impact factor: 2.772

4.  Preservation of renal function in children with myelomeningocele managed with basic newborn evaluation and close followup.

Authors:  Carin V Hopps; Kenneth A Kropp
Journal:  J Urol       Date:  2003-01       Impact factor: 7.450

5.  Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results.

Authors:  B Schurch; M Stöhrer; G Kramer; D M Schmid; G Gaul; D Hauri
Journal:  J Urol       Date:  2000-09       Impact factor: 7.450

6.  Long-term analysis of suprapubic cystostomy drainage in patients with neurogenic bladder.

Authors:  S Nomura; T Ishido; J Teranishi; K Makiyama
Journal:  Urol Int       Date:  2000       Impact factor: 2.089

Review 7.  Systematic review of risk factors for urinary tract infection in adults with spinal cord dysfunction.

Authors:  P G Shekelle; S C Morton; K A Clark; M Pathak; B G Vickrey
Journal:  J Spinal Cord Med       Date:  1999       Impact factor: 1.985

8.  Urodynamic effects of alpha1-blocker tamsulosin on voiding dysfunction in patients with neurogenic bladder.

Authors:  Hidehiro Kakizaki; Kaname Ameda; Shinya Kobayashi; Hiroshi Tanaka; Takashi Shibata; Tomohiko Koyanagi
Journal:  Int J Urol       Date:  2003-11       Impact factor: 3.369

9.  Botulinum-a toxin detrusor injection as a novel approach in the treatment of bladder spasticity in children with neurogenic bladder.

Authors:  H Schulte-Baukloh; Th Michael; B Stürzebecher; H H Knispel
Journal:  Eur Urol       Date:  2003-07       Impact factor: 20.096

10.  Intermittent self catheterization for patients with urinary incontinence or difficulty emptying the bladder.

Authors:  P Oakeshott; G M Hunt
Journal:  Br J Gen Pract       Date:  1992-06       Impact factor: 5.386

View more
  2 in total

1.  A Systematic Review of the Scientific Literature for Rehabilitation/Habilitation Among Individuals With Pediatric-Onset Spinal Cord Injury.

Authors:  Amanda McIntyre; Cristina Sadowsky; Andrea Behrman; Rebecca Martin; Marika Augutis; Caitlin Cassidy; Randal Betz; Per Ertzgaard; M J Mulcahey
Journal:  Top Spinal Cord Inj Rehabil       Date:  2022-04-12

2.  Spinal cord injury and neurogenic lower urinary tract dysfunction: what do we know and where are we going?

Authors:  William Dodd; Kartik Motwani; Coulter Small; Kevin Pierre; Devan Patel; Samuel Malnik; Brandon Lucke-Wold; Ken Porche
Journal:  J Mens Health       Date:  2022-01-19       Impact factor: 0.537

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.